$1,000 invested AbbVie Inc. (2023)
NYSE · ABBV · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-09-11
Today you would have
$1,796
+$796 (+79.63%)
ABBVSPY (benchmark)
- Entry price
- $143.14
- Current price
- $257.12
- Shares
- 6.9864
- CAGR
- +17.21%
- Max Drawdown
- -20.74%
- vs SPY
- -29.72 pp
✦The story
A $1,000 investment in AbbVie at the beginning of 2023 reached $1,796 by July 2026, up +79.6%. This was the period when AbbVie navigated the loss of U.S. exclusivity on Humira, offsetting it with newer immunology drugs Skyrizi and Rinvoq. The S&P 500 gained +109.4% over the same stretch.
#Related scenariosfor comparison
Other years for ABBV